NCT06995677
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06995677
Title Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
Acronym SURF302
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Tyra Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Tri Valley Urology - Murrieta RECRUITING Murrieta California 92562 United States Details
Genesis Research RECRUITING San Diego California 92123 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Urology Associates PC RECRUITING Nashville Tennessee 37209 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field